Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF

Int J Exp Pathol. 2015 Feb;96(1):21-30. doi: 10.1111/iep.12107. Epub 2014 Dec 21.

Abstract

Recent studies have shown a positive association of cancer and obesity, but the morphological and molecular mechanisms involved in this relationship are still unknown. This study analysed the impact of long-term obesity on rat prostate, focusing on stromal changes. Male adult Wistar rats were treated with high-fat diet to induce obesity, while the control group received a balanced diet. After 30 weeks of feeding, the ventral prostate was analysed by immunohistochemistry for cell proliferation, smooth muscle α-actin, vimentin, chondroitin sulphate and metalloproteinases (MMP-2 and 9). The content of androgen receptor (AR), oestrogen receptors (ERs) and vascular endothelial growth factor (VEGF) was measured by Western blotting, and activity of catalase and Glutathione-S-Transferase (GST) were quantified by enzymatic assay. Long-term obesity decreased testosterone plasma levels by 70% and resulted in stromal prostate hyperplasia, as evidenced by increased collagen fibres. Such stromal hyperplasia was associated with increased number of blood vessels and raised VEGF content, and increased expression of chondroitin sulphate, vimentin, α-actin and MMP-9. In spite of the high cell density in prostate, the proliferative activity was lower in the prostates of obese rats, indicating that hyperplasia was established during the early phases in this obesity model. AR levels increased significantly, whereas the ERα decreased in this group. Moreover, the levels of catalase and GST were changed considerably. These findings indicate that long-term obesity, besides disturbing the antioxidant control, causes intense stromal remodelling and release of factors that create an environment that can promote proliferative disorders in the gland, culminating with diffuse hyperplasia.

Keywords: MMP-9; androgen receptor; hyperplasia; obesity; prostate; stromal remodelling.

MeSH terms

  • Animals
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Catalase / metabolism
  • Cell Proliferation
  • Cellular Microenvironment
  • Disease Models, Animal
  • Extracellular Matrix / metabolism*
  • Glutathione Transferase / metabolism
  • Insulin / blood
  • Male
  • Malondialdehyde / metabolism
  • Matrix Metalloproteinase 9 / metabolism*
  • Obesity / complications*
  • Oxidation-Reduction
  • Prostate / enzymology*
  • Prostate / pathology
  • Prostatic Hyperplasia / blood
  • Prostatic Hyperplasia / enzymology
  • Prostatic Hyperplasia / etiology*
  • Prostatic Hyperplasia / pathology
  • Rats, Wistar
  • Receptors, Androgen / metabolism
  • Risk Factors
  • Stromal Cells / enzymology*
  • Stromal Cells / pathology
  • Testosterone / blood
  • Time Factors
  • Up-Regulation
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Biomarkers
  • Blood Glucose
  • Insulin
  • Receptors, Androgen
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Testosterone
  • Malondialdehyde
  • Catalase
  • Glutathione Transferase
  • Matrix Metalloproteinase 9
  • Mmp9 protein, rat